Pricing Log in Create free account

Codexis, Inc. (CDXS) vs enGene Therapeutics Inc (ENGN)

Codexis, Inc. and enGene Therapeutics Inc are both Biotechnology companies. Codexis, Inc. and enGene Therapeutics Inc are of similar size ($112.6M and $111.7M). enGene Therapeutics Inc has the higher net margin (0.00% vs −39.6%) and the higher return on invested capital (0.00% vs −151.2%). Across the 13 metrics below, enGene Therapeutics Inc leads on 8 and Codexis, Inc. on 5.

Valuation

Metric CDXS ENGN Biotechnology median
P/E n/m n/m 10.60
P/S 1.25 n/m 9.40
P/B 2.96 0.53 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.86 0.66
EV/Sales 0.98 n/m 9.02
Earnings yield (31.78%) (117.61%) (32.88%)
Free cash flow yield (12.49%) (84.73%) (23.13%)

Profitability

Metric CDXS ENGN Biotechnology median
Gross margin 87.02% — 68.51%
Operating margin (35.61%) 0.00% 0.00%
Net margin (39.55%) 0.00% 0.00%
Free cash flow margin (15.66%) 0.00% 0.00%
Return on equity (69.36%) (60.50%) (51.96%)
Return on assets (23.79%) (48.84%) (46.06%)
Return on invested capital (151.17%) 0.00% 0.00%

Growth

Metric CDXS ENGN Biotechnology median
Revenue growth (TTM) 35.89% — 6.76%
EPS growth (last fiscal year) 43.82% (56.85%) 29.88%
Revenue growth, 5-year CAGR 0.38% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDXS ENGN Biotechnology median
Debt to equity 1.03 0.11 0.00
Current ratio 3.06 10.21 4.97
Net debt to EBITDA 1.11 1.42 1.01

Dividend

Metric CDXS ENGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CDXS ENGN Biotechnology median
Market cap 111.70m 112.59m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack